SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending due to a massive volume spike and price surge, triggering multiple trading halts, as community discussion focuses on its extremely low float and high insider ownership for a potential short squeeze. Many are comparing it to recent explosive SPACs, with speculative targets suggesting significant upside, fueled by talking points like a rumored "sex toy manufacturer" acquisition. The stock's momentum reflects its position as a key play in the current "SPAC mania" for micro-float tickers.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is rapidly trending due to a potent combination of its extremely low share float and a potential short squeeze, driving significant momentum. The recent announcement of a strategic manufacturing partnership, expected to boost production margins, further amplifies investor interest. The community is actively discussing strong buying defense and a "textbook" short squeeze play as the company continues to expand global adoption of its fingerprint drug screening technology.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings (ONDS) is trending due to recent autonomous system orders and the FCC's ban on foreign-made drones, which significantly boosts its role in the domestic market. The community is actively discussing a potential short squeeze and anticipating a significant price breakout, with many seeing dips as buying opportunities. This positions Ondas as a crucial player in the growing defense and critical infrastructure sectors for autonomous and counter-drone solutions.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending after the FDA issued a Complete Response Letter for its relacorilant hypertension indication, triggering a sharp stock decline and intense community debate. Investors are divided, with many viewing the sell-off as an overreaction given the company's existing profitable drug and other pipeline programs, while others express caution regarding potential delays and future prospects.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending following its recent FDA approval of NEREUS, the first new motion sickness treatment in over four decades, validating a significant pipeline asset. Community discussion highlights the drug's broader potential for GLP-1 induced nausea, fueling speculation of substantial upside, a potential short squeeze, and even a buyout, given the company's strong financial standing and additional upcoming regulatory catalysts.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following its CEO's strategic insights on CNBC and news of spinning off its cloud business into ChronoScale, a move seen by many as unlocking significant value and clarifying its pure-play AI data center infrastructure focus. The community is actively discussing sustained demand from hyperscalers and strong analyst confidence ahead of its upcoming earnings report, fueling bullish sentiment despite recent price volatility. This strategic realignment aims to capitalize on the booming AI infrastructure market with a clearer business model and substantial contracted revenue.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst a wave of strong bearish sentiment, largely attributed to sustained selling pressure, high short interest, and year-end tax loss harvesting. The community is actively discussing the recent FDA approval of Novo Nordisk's oral Wegovy pill, seeing a potential for partnership and a significant catalyst for HIMS's future growth in GLP-1 offerings, alongside its ongoing expansion in D2C lab testing and international markets. Despite current frustration, many long-term investors are using this dip as a buying opportunity, anticipating a strong reversal.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after rival Corcept Therapeutics received an FDA Complete Response Letter for its Cushing's syndrome drug, effectively removing a near-term competitor for Xeris's Recorlev. The community is buzzing with bullish sentiment, emphasizing Recorlev's blockbuster potential and the significant undervaluation of XERS, further supported by advancing pipeline assets like XP-8121 and robust gross margins.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending due to the FDA's acceptance and priority review of its supplemental New Drug Application for AXS-05 in Alzheimer's disease agitation, with an action date anticipated in the near future. This significant regulatory milestone, combined with growing sales of its existing CNS therapies like Auvelity, has ignited immense optimism within the community, with many anticipating substantial long-term value and discussing breakthrough potential.

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

Motorola Solutions ($MSI) is trending following strategic acquisitions in advanced communications and AI-powered video monitoring, reinforcing its leadership in mission-critical technology for public safety and enterprise security. Community sentiment reflects a strong focus on institutional accumulation, evident in large dark pool trades and technical indicators suggesting the stock is oversold, signaling potential for a reversal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Citing channel checks, Wedbush analyst Daniel Ives stated that the company experienced increased momentum in the field due to its cyber platform approach.&nbsp;</li><li>According to the analyst, the Street is underestimating the growth potential for CrowdStrike.&nbsp;</li><li>The stock has increased by about 59% this year.</li></ul>CrowdStrike Holdings, Inc. (CRWD) stock showed a muted reaction to a positive analyst action in Monday’s early premarket session. The cybersecurity company’s stock has gained about 59% this year.On Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/CRWD">CrowdStrike stock</a> remained ‘bullish’ as of early Monday, while the message volume remained ‘high.’<h2 class="st-heading-2">Why CrowdStrike Analyst Is Upbeat</h2>In a note released late Sunday, Wedbush analyst Daniel Ives maintained an ‘Outperform’ rating and upped the price target for the stock to $600 from $525. Citing channel checks, the analysts stated that the company experienced increased momentum in the field due to its cyber platform approach.&nbsp;“CrowdStrike remains one of our favorite tech names, and we are seeing deal momentum spread, with AI [artificial intelligence] also a clear tailwind for this well-positioned tech leader,” Ives said.&nbsp; “We believe increased market and mind share is happening for CrowdStrike among new and existing customers.”The analyst noted that since the start of the calendar year 2025, revenue tied to cyber-AI products has been significantly higher than the year-ago period. He also added that the company is well-positioned to continue capitalizing on the AI cybersecurity trend due to the strength and stickiness of the Falcon platform.&nbsp;“We believe the Street is underestimating the growth potential for CrowdStrike as a second/third derivative beneficiary of the AI Revolution,” Ives said. According to the analyst, in a bull-case scenario, the stock could hit $700 over the next year.<h2 class="st-heading-2">What Retail Says About CrowdStrike</h2>A bullish analyst noted that the leading cybersecurity companies are all breaking out of a massive base, adding that the industry will likely lead the market next.<stembedurl>https://stocktwits.com/Albino_Trader123/message/634646348</stembedurl>Another user suggested that the stock could easily reach $800 as long as the market participates.<stembedurl>https://stocktwits.com/holdingbags/message/634593049</stembedurl>CrowdStrike ended Friday’s session up 0.80% at $543.01.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/palantir-rises-premarket-ahead-of-q3-analyst-sees-trillion-dollar-potential/cL2Z6HAR3zb">Palantir Rises Premarket Ahead of Q3: Analyst Sees Trillion-Dollar Potential, Hikes Target</a>

In this photo illustration, the CrowdStrike Holdings logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

CrowdStrike Stock Rises Premarket: Analyst Bumps Up Price Target By 14% On Optimism Over Cyber Platform Approach

Wedbush’s Daniel Ives said CrowdStrike remains one of his favorite tech names, with rising deal momentum and AI serving as a clear tailwind.

Equity

Wedbush’s Daniel Ives said CrowdStrike remains one of his favorite tech names, with rising deal momentum and AI serving as a clear tailwind.



CrowdStrike Holdings Inc. (CRWD) has garnered a cautious outlook from Wall Street analysts, despite stronger-than-expected second-quarter (Q2) earnings, due to tempered expectations for the back half of the year.The cybersecurity provider reported Q2 revenue of $1.17 billion and an adjusted earnings per share (EPS) of $0.93, both of which exceeded the analysts' consensus estimates of $1.15 billion and $0.83, respectively, according to Fiscal AI data. For FY2026, the company expects revenue to be between $4.749 billion and $4.805 billion, compared to an estimated $4.77 billion.<a href="https://stocktwits.com/symbol/CRWD">CrowdStrike stock</a> traded over 3% lower in Thursday’s premarket. On Stocktwits, retail sentiment toward the stock remained in ‘extremely bullish’ territory while message volume shifted to ‘extremely high’ from ‘normal’ levels in 24 hours.<figure class="image"><img style="aspect-ratio:936/109;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_28_065336_png_1f68350617.webp" alt="CRWD’s Sentiment Meter and Message Volume as of 06:50 a.m. ET on Aug.28, 2025 | Source: Stocktwits" width="936" height="109"><figcaption>CRWD’s Sentiment Meter and Message Volume as of 06:50 a.m. ET on Aug.28, 2025 | Source: Stocktwits</figcaption></figure>The stock experienced a 1,717% increase in user message count over 24 hours. A bullish Stocktwits user expressed optimism about the earnings.<stembedurl>https://stocktwits.com/odinhorse/message/626826326</stembedurl>Canaccord dropped its price target to $430 from $475, stating that while net-new annual recurring revenue (ARR) jumped to $221 million from $194 million in the previous quarter, overall ARR and subscription revenue growth continued to decelerate year-on-year. Achieving further growth could be challenging, the firm said.Bernstein trimmed its target to $343 from $371 and maintained a ‘Market Perform’ rating. The firm pointed to a dip in subscription revenue growth to 20.1% YoY, an impact it said is tied to a service outage last July.&nbsp;The firm noted that while CrowdStrike outperformed its revenue guide by $21 million, the company only nudged up its full-year forecast by $3 million, suggesting a softening in subscription growth expectations for the remainder of the year.Jefferies analyst Joseph Gallo reduced his target to $500 from $530, maintaining a ‘Buy’ rating. CrowdStrike stock has gained over 23% in 2025 and over 59% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pure-storage-stock-rips-higher-premarket-what-s-driving-the-rally/chs65bbRdmJ">Pure Storage Stock Rips Higher Premarket: What’s Driving The Rally?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The CrowdStrike Holdings, Inc. logo appears on the screen of a smartphone in Reno, United States, on December 1, 2024.

CrowdStrike Draws Caution From Wall Street Over Growth Outlook, But Retail Goes Contrarian

Canaccord stated that while net-new annual recurring revenue (ARR) jumped to $221 million from $194 million in the previous quarter, overall ARR and subscription revenue growth continued to decelerate year-on-year. 

Morgan Stanley analyst Keith Weiss downgraded cybersecurity giant CrowdStrike Holdings Inc. (CRWD), citing concerns that its strong rally has largely priced in upcoming growth.&nbsp;As per TheFly, Weiss rated the stock as ‘Equal Weight’, down from the previous ‘Overweight’ rating and modestly raised the price target to $495 from $490, suggesting a tempered view on the cybersecurity firm's future upside.Following the downgrade,&nbsp;<a href="https://stocktwits.com/symbol/CRWD">CrowdStrike stock&nbsp;</a>inched lower by 0.4% on Monday afternoon.The firm noted that CrowdStrike shares have climbed approximately 50% from their April lows, leaving limited room for further gains.&nbsp;“The expected second half of 2025 growth acceleration now looks well priced into the stock,” Weiss told investors in a research note, signaling that much of the anticipated progress is already reflected in the current valuation.While still praising CrowdStrike’s long-term strategic positioning in cybersecurity, the analyst expressed caution around the stock’s near-term potential.&nbsp;The analyst opined that despite its competitive moat and growth trajectory, the recent surge may have diminished the margin for additional upside.The company’s first-quarter (Q1)&nbsp;revenue climbed 20% year over year (YoY) to $1.103 billion, slightly below the $1.105-billion consensus estimate as per Finchat data.However, the adjusted earnings per share (EPS) of $0.73 surpassed the analysts' consensus estimate of $0.66. The company noted that the adjusted subscription gross margin contracted YoY to 80% from 81%.CrowdStrike sees second-quarter (Q2) adjusted EPS and revenue of $0.82 to $0.84 and $1.1447 billion to $1.1516 billion, respectively.On Stocktwits, retail sentiment toward CrowdStrike remained in ‘bullish’ territory amid ‘high’ message volume levels.<figure class="image"><img style="aspect-ratio:810/96;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_14_at_12_30_34_PM_png_1401cb34ae.webp" alt="CRWD’s Sentiment Meter and Message Volume as of 12:15 p.m. ET on July 14, 2025 | Source: Stocktwits" width="810" height="96"><figcaption>CRWD’s Sentiment Meter and Message Volume as of 12:15 p.m. ET on July 14, 2025 | Source: Stocktwits</figcaption></figure>CrowdStrike stock has added over 39% year-to-date and over 26% in the last 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bitmine-stock-rips-as-eth-treasury-tops-500-million/ch89Ro6R5nR">BitMine Stock Rips As ETH Treasury Tops $500M, But Retail Remains Cautious</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The CrowdStrike logo is being displayed on a smartphone in this photo illustration in Brussels, Belgium, on July 19, 2024. 

Morgan Stanley Downgrades CrowdStrike Amid Price Surge, But Retail Finds No Reason To Be Pessimistic

The firm downgraded the stock to ‘Equal Weight’, citing limited upside potential after a 50% rally. 

CrowdStrike Holdings, Inc. (CRWD) shares declined over 7% in Wednesday’s premarket after analysts downgraded the stock following a first-quarter (Q1) revenue miss and soft guidance.The cybersecurity vendor’s Q1 revenue grew 20% year-on-year (YoY) to $1.10 billion, marginally missing the consensus estimate of $1.105 billion, as per Finchat data.The adjusted earnings per share (EPS) of $0.73 surpassed an estimate of $0.66.BofA lowered its rating on the stock from ‘Outperform’ to ‘Neutral’, but increased the price target to $470 from $420, as per TheFly.&nbsp;The firm remains positive on CrowdStrike's core business and growth outlook, but believes the current valuation limits further gains.&nbsp;The new target implies only about a 3% upside from the stock’s current levels.&nbsp;Notably, the company’s sales growth slowed to below 20% in the first half of fiscal year 2026. While BofA anticipates growth to rebound to around 22% in the second half due to renewals related to CCP (customer commitment packages), it expects a longer-term slowdown in growth over the coming years.Canaccord analyst Kingsley Crane lowered his rating on CrowdStrike to ‘Hold’ from ‘Buy’, while increasing the price target to $475 from $420.&nbsp;In a note to investors, Crane noted that although the company delivered strong Q1 results, its profit margins were weaker than those of the same quarter last year.&nbsp;He expressed optimism about initial signs of growth within the Flex customer segment and said CrowdStrike’s performance following the July 19 incident of a faulty update was “truly exceptional.”&nbsp;However, Canaccord now sees a more balanced risk/reward profile, given the stock is trading at approximately 21 times projected 2026 revenue.Evercore ISI lowered its rating on CrowdStrike to ‘In Line’ from ‘Outperform’ and reduced the price target to $440 from $450.&nbsp;In a note to investors, the brokerage stated that the company delivered a well-executed Q1, although it fell short of being outstanding.&nbsp;The firm also highlighted increasing investor concerns regarding several unresolved issues at CrowdStrike and indicated that it is adopting a more cautious stance.On Stocktwits, retail sentiment around CrowdStrike remained in ‘extremely bullish’ territory.<figure class="image"><img style="aspect-ratio:638/72;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_04_071806_png_d1adc7941c.webp" alt="CRWD's Sentiment Meter and Message Volume as of 07:40 a.m. ET on June 4, 2025 | Source: Stocktwits" width="638" height="72"><figcaption>CRWD's Sentiment Meter and Message Volume as of 07:40 a.m. ET on June 4, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user is&nbsp;buying the dip in the shares.<stembedurl>https://stocktwits.com/Gammamoney/message/616737720</stembedurl>Another user noted that buying the dip has become a pattern after every quarterly earnings report of the company.<stembedurl>https://stocktwits.com/79dolladoc/message/616729053</stembedurl><a href="https://stocktwits.com/symbol/CRWD">CrowdStrike</a> stock has gained over 42% in 2025 and over 59% in the last 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nvidia-reclaims-market-cap-crown-from-microsoft/chkuPmLRbw7">Nvidia Reclaims Market Cap Crown From Microsoft As AI Mania Persists; Retail Stays Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

CrowdStrike Stock Slumps Post Q1 Print As Analysts Turn Cautious: Retail Seizes Pullback Opportunity

Multiple analysts downgraded the stock, citing valuation concerns, soft margins, and a more balanced risk/reward outlook.

CrowdStrike Holdings, Inc. (CRWD) shares fell sharply in Tuesday’s post-market session after the cybersecurity vendor announced a small quarterly revenue miss and soft topline guidance. The company also announced a $1 billion stock buyback authorization.Austin, Texas-based CrowdStrike reported adjusted earnings per share (EPS) of $0.73 compared to the year-ago quarter’s $0.79 and the Finchat-compiled consensus of $0.66.Revenue climbed 20% year over year (YoY) to $1.103 billion,&nbsp;slightly below the $1.105-billion consensus estimate and the upper end of the guided range. The topline growth slowed from 25% in the previous quarter.Among key user metrics, the annual recurring revenue (ARR) rose 22% and stood at $4.44 billion as of April 30, with $193.8 million being the net new ARR.&nbsp;The company noted that the adjusted subscription gross margin contracted YoY to 80% from 81%.CEO George Kurtz said, “We started the fiscal year with record Q1 large deal and MSSP momentum alongside sustained 97% gross retention and consistently strong net retention as the market consolidates on Falcon as its cybersecurity platform of choice for the agentic AI era.”Looking ahead, CrowdStrike guided second-quarter adjusted EPS and revenue to $0.82-$0.84 and $1.1447 billion-$1.1516 billion.respectively.Analysts, on average, expect the numbers to be at $0.81 and $1.160 billion, respectively.The company raised its full-year EPS guidance to $3.44-$3.56 from $3.33-$3.45 but maintained the revenue outlook at $4.7435 billion-$4.8055 billion. This compares to the guidance of $3.45 and $4.79 billion, respectively.CFO Burt Podbere said, “Our conviction in net new ARR re-acceleration and margin expansion in the second half of fiscal year 2026 is reinforced by Falcon Flex deal momentum and early Falcon Flex expansions, strong competitive win rates and robust pipeline for the second half of fiscal year 2026.”On Stocktwits, retail sentiment toward the CrowdStrike stock was ‘bullish’ (64/100) by late Tuesday, and the message volume on the stream was ‘high.’<figure class="image"><img style="aspect-ratio:617/56;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_03_at_10_09_16_PM_png_c4fd12b559.webp" alt="Screenshot 2025-06-03 at 10.09.16 PM.png" width="617" height="56"><figcaption>CRWD sentiment and message volume as of 10:09 p.m. ET, June 3 | source: Stocktwits</figcaption></figure>The stock was among the top five trending tickers on the platform by late Tuesday.A bullish watcher recommended buying the dip in the stock, calling it a ‘golden opportunity.’<stembedurl>https://stocktwits.com/23ChaseColeman23/message/616717931</stembedurl>Another user premised their bullishness on the prospects as the cyberwars and hackers prompt increased spending on cybersecurity.<stembedurl>https://stocktwits.com/Annie_Preferred/message/616715294</stembedurl>CrowdStrike stock fell 6.48% to $457.09 in Tuesday’s after-hours, but it is up about 43% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fed-lisa-cook-trump-tariffs-raising-inflation/chkrhqWRbvv">Fed’s Lisa Cook Sees Trump Tariffs Raising Inflation, Stressing Labor Market</a>

CrowdStrike Stock Slides On Mixed Q1, Soft Revenue Guidance: Retail Rushes In To Buy The Dip

The company said its conviction in net new ARR re-acceleration and margin expansion in the second half of fiscal year 2026 is reinforced by Falcon Flex deal momentum and early Falcon Flex expansions.

Should iShares Russell Top 200 ETF (IWL) Be on Your Investing Radar?

Shares of cybersecurity company CrowdStrike Holdings, Inc. (CRWD) received a sizable price target boost on Sunday following Wedbush’s channel checks.Analyst Daniel Ives upped the price target for Crowdstrike stock to $475 from $395 and maintained an ‘Outperform’ rating. He believes the stock can hit $550 over the next year in a bull-case scenario, as the company executes its core growth strategy.&nbsp;The analyst said his checks revealed increased momentum for the company’s cyber platform approach into the following year. He added that Cloud, Identity, Logscale, and better-than-expected trends in Data Protection and Charlotte artificial intelligence drive the strength.&nbsp;Ives said Charlotte AI saw more than 100 deals in the recent quarter, and momentum accelerated further in the next quarter.“While AI continues to be top of mind for enterprises heading into an important year for AI monetization, we are seeing more module add-ons within CRWD’s core verticals,” he added.Ives lauded the company for integrating AI across its portfolio to capitalize on elevated demand for advanced cyber solutions to protect IT and AI infrastructure across the tech stack.&nbsp;The analyst said, “CRWD remains the gold standard for cybersecurity with the company in the early innings of its multi-year growth story, with NNARR [net new annual recurring revenue] growth expected to reaccelerate in the 2H26.”“We also continue to believe the cybersecurity subsector could be an outperformer within the broader tech space as these resilient spending trends play out, led by the F1 cyber racing car trailblazer CrowdStrike.”Last week, CrowdStrike said it expects its fiscal year 2026 first-quarter results to align with or exceed its guidance. It also reaffirmed its fiscal year 2026 guidance and announced<a href="https://stocktwits.com/news-articles/markets/equity/crowdstrike-to-reduce-workforce/chiBWWQRbjI">&nbsp;plans to trim 5% of jobs</a>, translating to 500 positions.On Stocktwits, retail sentiment toward CrowdStrike stock stayed ‘neutral’ (42/100) by late Sunday, while the message volume was ‘high.’<figure class="image"><img style="aspect-ratio:622/54;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_11_at_9_30_02_PM_png_35f645808b.webp" alt="Screenshot 2025-05-11 at 9.30.02 PM.png" width="622" height="54"><figcaption>CRWD sentiment and message volume as of 9:30 p.m. ET, May 11 | &nbsp;source: Stocktwits</figcaption></figure>A bearish watcher said the stock price failed to make higher highs and is poised to test the $400 level once it closes below the $406.68 level.<stembedurl>https://stocktwits.com/OnlyFibs/message/614163114</stembedurl>But another user expressed confidence in the stock rebounding to $440 in the near term.<stembedurl>https://stocktwits.com/muskegbaymomentum/message/614141745</stembedurl>CrowdStrike stock settled Friday’s session down 4.215% at $410.57 but is up about 20% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cybersecurity ‘Gold Standard’ CrowdStrike Gets Big Price Target Boost On AI-Powered Platform Approach: Retail Sentiment Lags

The analyst said his checks revealed increased momentum for the company’s cyber platform approach into the next year.

CrowdStrike Holdings, Inc.'s (CRWD) shares defied the tech sector sell-off on Tuesday and ended modestly higher for the day.&nbsp;After the bell, Crowdstrike CEO George Kurtz reassured investors by emphasizing the company's immunity to President Donald Trump's sweeping tariffs.Speaking on CNBC's ‘Mad Money’ show hosted by Jim Cramer, Kurtz<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=AieXCP4yYX0">&nbsp;said</a>&nbsp;CrowdStrike could shine in an environment where cyberattacks are increasing, and geopolitical conditions necessitate the need to save costs.The executive also explained about the company's tariff immunity. "The beauty about our business is we don't have any hardware; we're not subject to the tariffs," he said.Kurtz said CrowdStrike and the cybersecurity industry are both great in the current geopolitical environment.&nbsp;&nbsp;While discussing Alphabet, Inc.'s (GOOG) (GOOGL) recent acquisition of cybersecurity startup Wiz,&nbsp;Kurtz said the deal validates the cybersecurity market, given it was the largest acquisition of a venture-backed company in recent times.He noted that CrowdStrike is one of the largest cloud security companies by revenue, with $600 million in annualized recurring cloud revenue, and that the company remains undervalued when compared to its prospects.CrowdStrike is coming off a turbulent year that included fallout from a major Microsoft outage linked to one of its updates, which temporarily disrupted key services and weighed on investor sentiment.In early March, the Austin, Texas-based company reported<a href="https://stocktwits.com/news-articles/markets/equity/crowdstrike-stock-plunges-after-2025-q4-results/cheZAc0R64">&nbsp;a fourth-quarter beat</a> and issued a mixed forward guidance.A bullish stock watcher on the Stocktwits platform named CrowdStrike among "safe-haven" stocks.<stembedurl>https://stocktwits.com/Honest_Bull/message/610956767</stembedurl>Another user said CrowdStrike is a stock to buy, given that top tech firms will not hold back on their cybersecurity spending. They called it tariff- and recession-proof.<stembedurl>https://stocktwits.com/Nightdawgs21/message/610757022</stembedurl>CrowdStrike stock ended Tuesday's session up 0.21% at $325.04 even as the Nasdaq Composite plunged 2.15%; The stock is down merely 5% this year.Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/broadcom-announces-10-billion-dollars-stock-buy-back/chfVYWuRbJk">&nbsp;Broadcom Bucks Broader Market Sell-Off As Chipmaker Announces $10B Stock Buyback: Retail Sentiment Lags Amid Tariff Mayhem</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

CrowdStrike Chief Executive George Kurtz is photographed in the company's offices.

CrowdStrike CEO Declares Cybersecurity Stocks Safe From Trump Tariffs, Retail Investors Bite

"The beauty about our business is we don't have any hardware; we're not subject to the tariffs," he said.

Alphabet, Inc. (GOOGL) (GOOG) recently confirmed its agreement to acquire privately held cloud security platform company Wiz for $32 billion in cash. However, the deal did not send shivers down the spine of&nbsp;Wiz's peer CrowdStrike, Inc. (CRWD).Following a meeting with CrowdStrike CFO Burt Podbere, Jefferies analysts said the company viewed Alphabet's Wiz buy positively, The Fly reported. The executive opined that full integration of Wiz technology into the Google Cloud Platform will take time.&nbsp;Jeffries said CrowdStrike's agent offering is a competitive advantage compared to Wiz's agentless offering. The analyst also noted that Podbere expressed confidence in the second half of the fiscal year 2026's net new annual recurring revenue (ARR) and cash flow generation.The analysts noted that the company prioritized the Falcon Flex platform, which allows customers to maximize their security investment with a flexible licensing agreement customized to meet their organization's needs.&nbsp;The brokerage also expects CrowdStrike to benefit from vendor consolidation due to budget constraints amid an uncertain macroeconomic environment. However, founder and CEO George Kurtz said the company is firmly on the flight path to its $10 billion ending ARR goal.Jefferies has a 'Buy' rating and&nbsp;a $425 price target for<a href="https://stocktwits.com/symbol/CRWD">&nbsp;CrowdStrike stock.</a>Earlier this month, the company reported a slowdown in fourth-quarter operational metrics and issued mixed guidance, sending its stock lower in the session that followed the print.On Stocktwits, retail sentiment toward CrowdStrike stock stayed 'bearish,' and the message volume remained at 'extremely low' levels.&nbsp;<figure class="image"><img style="aspect-ratio:631/133;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/crwd_sentiment_png_43b1f2ee18.webp" alt="crwd-sentiment.png" width="631" height="133"><figcaption>CRWD &nbsp;sentiment and message volume March 20, as of 12:30 am ET | Source:&nbsp;Stocktwits</figcaption></figure>A bearish watcher expressed dissatisfaction over CrowdStrike's what they perceived to be pricier valuation.<stembedurl>https://stocktwits.com/I_hate_intel_mu_amd/message/608421336</stembedurl>CrowdStrike stock trades at a forward price-earnings (P/E) multiple of 109 times, according to Koyfin.The stock ended Thursday's session up 3.28% to $375.05, and it is up 9.6% year-to-date.&nbsp;The Koyfin-compiled consensus price target for CrowdStrike is $408.36, implying nearly 9% upside potential.For updates and corrections email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/most-retail-traders-confident-of-netflix-stock-topping-1100-by-mid-2025/ch7NQmmRb2u">Most Retail Traders Bet On Netflix Topping $1,100 By Mid-2025, But A Stubborn Bearish Camp Lingers</a>

CrowdStrike Analyst Dismisses Alphabet-Wiz Threat, But Retail Sees Some Risks

Jeffries said CrowdStrike’s agent offering is a competitive advantage compared to Wiz’s agentless offering.

Crowdstrike Holdings, Inc. (CRWD) shares slumped in Wednesday’s premarket trading after the cybersecurity provider reported a slowdown in quarterly operational metrics and issued mixed guidance.&nbsp;The Austin, Texas-based company reported adjusted earnings per share (EPS) of $1.03 for the fourth quarter of the fiscal year 2025. The bottom-line result exceeded the year-ago&nbsp;figure of $0.95,&nbsp;beating the Finchat-compiled consensus of $0.86 per share.Revenue climbed 25% year over year (YoY) to $1.059 billion versus the $1.035-billion consensus estimate. However, the YoY growth decelerated from the third quarter’s 29%.The top- and bottom-line results also exceeded the company’s guidance that called for adjusted EPS of $0.84-$0.86 and revenue of $1.0287 billion to $1.0354 billion.Among the key operational metrics, annual recurring revenue (ARR) grew 23% YoY to $4.24 billion as of Jan. 31, 2025, with the net new ARR added during the quarter at $224.3 million. The ARR growth decelerated from 27% in the third quarter, but the net new ARR added improved from $153 million.The adjusted Subscription gross margin remained steady at 80%&nbsp;Founder and CEO George Kurtz said, “Delivering $224 million of net new ARR, which brings our ending ARR to $4.24 billion, places us firmly on the flight path to our $10 billion ending ARR goal.”He noted that Crowdstrike saw strong momentum in its next-generation SIEM, Cloud Security, and Identity Protection businesses, surpassing $1.3 billion in combined ending ARR.&nbsp;Kurtz also noted that accounts adopting its artificial intelligence (AI)-native Security Operations Center (SOC), Falcon Flex, added over $1 billion of in-quarter deal value.&nbsp;Looking ahead, the company guided first-quarter adjusted EPS and revenue to be $0.64 to $0.66 and $1.1006 billion to $1.1064&nbsp;billion, respectively. This compares to the $0.95 and $1.104 billion guidance, respectively.Crowdstrike expects its fiscal year 2026 adjusted EPS and revenue to be $3.33 to $3.45 and $4.744 billion to $4.806 billion, respectively. While the bottom-line guidance trailed the consensus of&nbsp;$3.85, the revenue guidance aligned with the average analysts’ estimate of $4.778 billion.On Stocktwits, retail sentiment toward the stock improved to ‘bullish’ (55/100) from the ‘bearish’ mood that prevailed a day ago. The message volume perked to an ‘extremely high’ level. The stock was among the top 10 trending tickers on the platform.<figure class="image"><img style="aspect-ratio:625/136;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/crwd_sentiment_951460a8c8.png" alt="crwd-sentiment.png" width="625" height="136"><figcaption>&nbsp;CRWD sentiment and message volume March 5, premarket as of 6:22 am ET | Source:&nbsp;Stocktwits</figcaption></figure>One bullish watcher shrugged off the soft earnings guidance and noted&nbsp;that this may be a good time to buy more shares.<stembedurl>https://stocktwits.com/janthony23/message/606807857</stembedurl><a href="https://stocktwits.com/symbol/CRWD">Crowdstrike stock</a> fell 8.04% to $358.79 in premarket trading,&nbsp;heading toward its lowest level in over a month.&nbsp;However, it is up 14% year-to-date.For updates and corrections, email newsroom@stocktwits.com&nbsp;

Crowdstrike Stock Plunges After Q4 Print As Investors Fret Over Slowing Growth, Weak Earnings Guidance: Retail Mood Flips To 'Bullish'

Annual recurring revenue grew 23% year over year to $4.24 billion, slower than the 27% growth in the third quarter.

IWL
iShares Russell Top 200 ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IWL News

IWLiShares Russell Top 200 ETF